QSC Tirzepatide (LY3298176) is a high-purity peptide compound developed for research purposes. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist has shown significant potential in metabolic research applications.
The molecular structure of QSC tirzepatide features a lysine side chain with PEG modification, enhancing water solubility while maintaining biological activity. Research indicates this compound may offer advantages over single-receptor agonists in certain metabolic studies.
In clinical research settings, QSC tirzepatide has demonstrated potential effects on glucose regulation and metabolic parameters. The compound's dual agonist properties make it particularly interesting for investigating new approaches to metabolic conditions.
Our QSC tirzepatide is supplied as a white powder with 99.9% purity, packaged in research-appropriate vials. Each batch undergoes rigorous quality control testing to ensure consistency and reliability for research applications.
Storage recommendations for QSC tirzepatide include maintaining the product in a cool, dry environment protected from light. Avoid repeated freeze-thaw cycles and minimize exposure to air to preserve stability.
This product is intended for research use only by qualified professionals in laboratory settings. Not for human consumption or diagnostic use.